Less Nasal Trauma
Randomized controlled trials have shown significantly lower rates of nasal trauma associated with Nasal High Flow therapy compared to nasal CPAP1,2,3.
No Significant Difference in Adverse Events
Clinical studies have concluded that there appears to be no significant difference in other serious adverse events (i.e. pneumothorax) when compared to nasal CPAP1,2,3.
Improved Mother-infant Bonding
Surveys of practice from around the world describe that parents are able to bond more easily with infants on Nasal High Flow therapy10,11,12.
Comfortable and Well Tolerated
Research and surveys of practice have found that Optiflow™ Junior is comfortable and well-tolerated10,11, 12, 13.